Unlock instant, AI-driven research and patent intelligence for your innovation.

Mutated e. coli heat-labile enterotoxin

A heat-resistant enterotoxin and Escherichia coli technology, applied in the direction of viruses, antibacterial drugs, antiviral agents, etc., can solve the problems of high toxicity and limited clinical application

Active Publication Date: 2012-07-18
DEV CENT FOR BIOTECHNOLOGY
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the high toxicity of wild-type LT limits its clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0019] Example 1: Construction of encoding wild-type LT A and LT mutant LT A gene

[0020] A 1.8-kb DNA fragment of the LT gene, including subunit A and subunit B, was isolated from human enterotoxigenic E. coli H10407 and cloned into pBluescript IIKS(-) vector (pBluescript-LThWT). The nucleotide sequence (SEQ ID NO: 6) of the LT gene (encoding subunits A and B) and the amino acid sequence (SEQ ID NO: 5) of the subunit A of the LT are as follows:

[0021] Nucleotide sequence of LT (SEQ ID NO: 6) (subunit A: 1-777; subunit B: 774-1148):

[0022] atgaaaaata taactttcat tttttttatt ttattagcat cgccattata tgcaaatggc 60

[0023] gacaaattat accgtgctga ctctagaccc ccagatgaaa taaaacgttc cggaggtctt

[0024] 120

[0025] atgcccagag ggcataatga gtacttcgat agaggaactc aaatgaatat taatctttat

[0026] 180

[0027] gatcacgcga gaggaacaca aaccggcttt gtcagatatg atgacggata tgtttccact

[0028] 240

[0029] tctcttagtt tgagaagtgc tcacttagca ggacagtcta tattatcagg atattccact

[0030] 300

[0031]...

Embodiment 2

[0206] Example 2: Preparation of wild type LT and mutant LT A LT

[0207]E. coli HB101 was transformed with the pBluescript II KS(-) vector containing native or mutant LT genes (including subunit A and subunit B genes). Native and mutant LTs were purified from cultures grown overnight in 3-liter shake flasks containing L-broth supplemented with 100 μg / ml ampicillin. Cells were collected by centrifugation, resuspended in TEAN buffer (0.2M NaCl, 50 mM Tris, 1 mM EDTA and 3 mM NaN3, pH 7.4), and lysed with a microfluidizer (Microfluidics Corporation, USA). After clarification of the lysate by centrifugation, LT was fractionated by addition of solid ammonium sulfate to 65% saturation. The preparation was then suspended in TEAN buffer, extensively dialyzed against the same buffer, and used as crude LT. Crude LT was chromatographed at 4°C on an immobilized D-galactose (Pierce, Rockford, IL) column equilibrated with TEAN buffer (Uesaka et al., 1994, Microbial Pathogenesis 16:71-76...

Embodiment 3

[0213] Example 3: Determination of wild-type LT and mutant-containing LT A Effect of LT on intracellular cAMP levels

[0214] Caco-2 cells (ATCC HTB-37) at 5×10 per well 4 Concentrations of cells were maintained in 24-well plates in MEM-α medium supplemented with 20% FBS, grown to near confluence, and incubated in 5% CO 2 Incubate for 30 min in MEM-α containing 1% FBS and 1 mM 3-isobutyl-1-methylxanthine (IBMX), then add toxin (Grant et al., 1994, Infection and Immunity 62:4270-4278) . Native or mutant LT was added to each well and incubated for 4 hours. Cells were then washed twice with cold PBS. Intracellular cAMP was extracted by adding 200 [mu]l 0.1 N HCl to each well and incubating for 15 minutes at room temperature. Supernatants of cell lysates were collected after addition of 0.1 N NaOH to each well (Cheng et al., 2000, Vaccine 18:38-49; Park et al., 1999, Experimental and Molecular Medicine 31:101-107). cAMP was measured with a cAMP enzyme immunoassay kit (Assay ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

This invention relates to a mutant E. coli heat-labile enterotoxin (LT) subunit A that can be used as an adjuvant. This subunit A mutant contains an amino acid substitution at a position corresponding to position 61 of a wild-type LT. An LT containing this mutated subunit A exhibits reduced toxicity compared to its wild type counterpart.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Patent Application Serial No. 11 / 779,419, filed July 18, 2007, the contents of which are hereby incorporated by reference. Background technique [0003] Enterotoxigenic E. coli strains cause diarrhea in humans and domesticated animals by producing two types of enterotoxins, heat-labile toxin (LT) and heat-stable toxin (ST) (Hofstra et al., 1984, J. Bio. Chem. 259:15182-15187). LT is functionally, structurally and immunologically related to cholera toxin (CT) (Clements et al., 1978, Infect. Immun. 21: 1036-1039). LT and CT are synthesized as holotoxin molecules consisting of five identical subunits B and one enzymatically active subunit A (AB 5 ) (Spangler, 1992, Microbio. Rev. 56(4): 622-647). The B pentamer binds to the ganglioside GM1 in the membrane of intestinal epithelial cells or any other GM1-containing cell (van Heyningen, 1974, Science 183:656-657). After subunit B bin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/02
CPCA61K2039/543A61K2039/5252C12N2760/16134A61K39/145A61K39/0258C07K14/425A61K39/39A61K2039/55544A61K39/12A61P31/04A61P31/12A61P31/14A61P31/16A61P31/18A61P31/20Y02A50/30C07K14/245A61K39/02C12N15/11C12N15/63
Inventor 徐悠深林阳生阮大同
Owner DEV CENT FOR BIOTECHNOLOGY